Form GSTR-2A- Details of auto drafted supplies Form GSTR-2B- Auto drafted ITC statement Interestingly, both the above-referred statement reflects details of inward supplies as well as details of an ...

TikTok's future in the United States depends entirely on the incoming president's support. President-elect Trump will be pushing for investors to see his show.

The RTX 5070 and RTX 5070 Ti have now been unveiled at CES 2025 as part of an announcement of four new GPUs. With many improvements, they’ll be more power-hungry than the RTX 40 series. However, those ...

The state of Maryland is facing a $3 billion budget shortfall. Gov. Wes Moore has announced significant budget cuts and has said he will hike taxes on the wealthiest residents to increase ...

Texas Instruments has a 12 month low of $155.46 and a 12 month high of $220.38. The company has a market capitalization of $180.17 billion, a price-to-earnings ratio of 36.71, a P/E/G ratio of 4. ...

A total of P4.2 billion was appropriated for the new Senate building in the 2025 national budget, bringing the total allocation to the structure to P23.5 billion since 2018. In Mav Gonzales’ Wednesday ...

The GSTR-2B (input tax credit) statement will now be generated two days later on Thursday, January 16, from the originally scheduled date of January 14, for the December 2024 tax period.

At a glance, these two cards are different in exactly all the areas you'd expect. The RTX 5070 Ti has more CUDA cores, VRAM, and a higher bandwidth. Due to these aspects, it also consumes more power ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

The Canadian government has approved Bunge Ltd.'s $8.2-billion US acquisition of Viterra Ltd., but the Agriculture Producers Association of Saskatchewan (APAS) says more action is needed to ...

Anavex Life Sciences Corp. announced that the Journal of Prevention of Alzheimer’s Disease published results from its Phase IIb/III study of blarcamesine (ANAVEX®2-73), an oral treatment for ...

“We are extremely pleased with these results of our Phase 2b clinical trial because they show that OST-HER2-treated patients achieved the primary endpoint of 12-month EFS in a statistically ...